Peder M. Andersen MD, Chief Executive Officer

Has 30 years of experience from large Pharma, medium Pharma and small/virtual biotech Pharma. He has held senior positions in Orion Pharma, Novo Nordisk, Astion Pharma and Forward Pharma A/S. With Forward he was as CEO/COO heading all development and IP activities and was instrumental in the IPO on the NY Nasdaq October 2014 (235M USD).